Literature DB >> 20528562

Knockdown of sensitive to apoptosis gene by small interfering RNA enhances the sensitivity of PC3 cells toward actinomycin D and etoposide.

Eun Sun Yang1, Yun Jeong Huh, Jeen-Woo Park.   

Abstract

Actinomycin D and etoposide induce the production of reactive oxygen species, which play an important causative role in apoptotic cell death. Sensitive to apoptosis gene (SAG) protein, a redox inducible zinc RING finger protein that protects mammalian cells from apoptosis by redox reagents, is a metal chelator and a potential reactive oxygen species scavenger. The present report show that knockdown of SAG expression in PC3 cells greatly enhances apoptosis induced by actinomycin D and etoposide. Transfection of human prostate cancer PC3 cells with SAG small interfering RNA (siRNA) markedly decreased the expression of SAG, enhancing the susceptibility of actinomycin D- and etoposide-induced apoptosis reflected by DNA fragmentation, cellular redox status and the modulation of apoptotic marker proteins. These results indicate that SAG may play an important role in regulating the apoptosis induced by actinomycin D and etoposide and the sensitizing effect of SAG siRNA on the apoptotic cell death of PC3 cells offers the possibility of developing a modifier of cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528562     DOI: 10.3109/10715762.2010.485996

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  2 in total

Review 1.  Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.

Authors:  Yi Sun; Hua Li
Journal:  Protein Cell       Date:  2012-11-08       Impact factor: 14.870

2.  Tat-fused recombinant human SAG prevents dopaminergic neurodegeneration in a MPTP-induced Parkinson's disease model.

Authors:  Eun Jeong Sohn; Min Jea Shin; Dae Won Kim; Eun Hee Ahn; Hyo Sang Jo; Duk-Soo Kim; Sung-Woo Cho; Kyu Hyung Han; Jinseu Park; Won Sik Eum; Hyun Sook Hwang; Soo Young Choi
Journal:  Mol Cells       Date:  2014-03-13       Impact factor: 5.034

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.